Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001144204-17-021331

VP, Chief Financial Officer acquired 80,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kolean Chad J VP, Chief Financial Officer 2017-04-18 Grant or award +80,000 80,000 D: show line 1 in the form
Loading xslF345X03/v464726_form4.xml…